While testing a new drug designed to treat chronic leukemia, researchers have discovered new markers that could identify which patients would receive maximum benefit from the treatment.
While testing a new drug designed to treat chronic leukemia, researchers have discovered new markers that could identify which patients would receive maximum benefit from the treatment.